Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes

Diabetes

Volumn 60, Issue 6, 2011, Pages 1752-1758

  Kacerovsky, Michaela ^a   Jones, John ^b,c   Schmid, Albrecht I ^a,d   Barosa, Cristina ^b   Lettner, Angelika ^a   Kacerovsky Bielesz, Gertrud ^a,e   Szendroedi, Julia ^a,e,f,g   Chmelik, Marek ^a,d   Nowotny, Peter ^f   Chandramouli, Visvanathan ^h   Wolzt, Michael ^d   Roden, Michael ^a,e,f,g  

^a Karl Landsteiner Institute for Endocrinology and Metabolism Vienna   (Austria)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c Portuguese Diabetes Association   (Portugal)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e HANUSCH HOSPITAL   (Austria)

^f LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^g UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; GLYCOGEN; GROWTH HORMONE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; PARACETAMOL GLUCURONIDE;

ADULT; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DRUG URINE LEVEL; FATTY ACID BLOOD LEVEL; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCOGEN CYCLING; GLYCOGEN LIVER LEVEL; GLYCOGEN METABOLISM; GLYCOGEN SYNTHESIS; GROWTH HORMONE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; PRIORITY JOURNAL;

ADULT; DIABETES MELLITUS, TYPE 1; FASTING; FEMALE; GLUCOSE; GLYCOGEN; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; POSTPRANDIAL PERIOD; YOUNG ADULT;

EID: 79959442449     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-1001     Document Type: Article

References (48)

1. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC. Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 1996;98:378-385 (Pubitemid 26255737)
2. Magnusson I, Rothman DL, Gerard DP, Katz LD, Shulman GI. Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes 1995;44:185-189
3. 13C nuclear magnetic resonance spectroscopy study. J Clin Invest 1995;95:783-787
4. Bischof MG, Krssak M, Krebs M, et al. Effects of short-term improvement of insulin treatment and glycemia on hepatic glycogen metabolism in type 1 diabetes. Diabetes 2001;50:392-398 (Pubitemid 32127297)
5. Kishore P, Gabriely I, Cui MH, et al. Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes. Diabetes 2006;55:659-666 (Pubitemid 43343221)
6. Bischof MG, Bernroider E, Krssak M, et al. Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia. Diabetes 2002;51:49-54 (Pubitemid 34517979)
7. Landau BR. Methods for measuring glycogen cycling. Am J Physiol Endocrinol Metab 2001;281:E413-E419
8. Hundal RS, Krssak M, Dufour S, et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 2000;49:2063-2069
9. Petersen KF, Krssak M, Navarro V, et al. Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis. Am J Physiol 1999;276:E529-E535 (Pubitemid 29157409)
10. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-942 (Pubitemid 13214364)
11. 2O for estimating rates of gluconeogenesis. Application to the fasted state. J Clin Invest 1995;95:172-178
12. Chandramouli V, Ekberg K, Schumann WC, Kalhan SC, Wahren J, Landau BR. Quantifying gluconeogenesis during fasting. Am J Physiol 1997;273:E1209-E1215
13. Jones JG, Fagulha A, Barosa C, et al. Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen. Diabetes 2006;55:2294-2300 (Pubitemid 44743627)
14. 13C-enrichment of human glucuronide from metabolic tracers. J Carbohydr Chem 2006;25:203-217
15. 2H NMR. Magn Reson Med 2001;45:156-158
16. Anderwald C, Bernroider E, Krssak M, et al. Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 2002;51:3025-3032
17. Naressi A, Couturier C, Devos JM, et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001;12:141-152 (Pubitemid 32510133)
18. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35-43 (Pubitemid 127454051)
19. Krssak M, Brehm A, Bernroider E, et al. Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes 2004;53:3048-3056 (Pubitemid 39564478)
20. Stingl H, Schnedl WJ, Krssak M, et al. Reduction of hepatic glycogen synthesis and breakdown in patients with agenesis of the dorsal pancreas. J Clin Endocrinol Metab 2002;87:4678-4685 (Pubitemid 35247061)
21. Krebs M, Stingl H, Nowotny P, et al. Prevention of in vitro lipolysis by tetrahydrolipstatin. Clin Chem 2000;46:950-954 (Pubitemid 30461265)
22. 13C NMR. Science 1991;254:573-576
23. Groop LC, Widén E, Ferrannini E. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 1993;36:1326-1331
24. Petersen KF, Price T, Cline GW, Rothman DL, Shulman GI. Contribution of net hepatic glycogenolysis to glucose production during the early postprandial period. Am J Physiol 1996;270:E186-E191
25. Roden M, Perseghin G, Petersen KF, et al. The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest 1996;97:642-648 (Pubitemid 26057081)
26. Stingl H, Chandramouli V, Schumann WC, et al. Changes in hepatic glycogen cycling during a glucose load in healthy humans. Diabetologia 2006;49:360-368 (Pubitemid 43185405)
27. Petersen KF, Laurent D, Rothman DL, Cline GW, Shulman GI. Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest 1998;101:1203-1209 (Pubitemid 28145235)
28. Magnusson I, Rothman DL, Jucker B, Cline GW, Shulman RG, Shulman GI. Liver glycogen turnover in fed and fasted humans. Am J Physiol 1994;266:E796-E803
29. Boden G, Cheung P, Homko C. Effects of acute insulin excess and de- ficiency on gluconeogenesis and glycogenolysis in type 1 diabetes. Diabetes 2003;52:133-137 (Pubitemid 36042117)
30. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004;350:664-671 (Pubitemid 38364625)
31. Hother-Nielsen O, Schmitz O, Bak J, Beck-Nielsen H. Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes. Diabetologia 1987;30:834-840 (Pubitemid 18003663)
32. Fasching P, Ratheiser K, Damjancic P, et al. Both acute and chronic near-normoglycaemia are required to improve insulin resistance in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993;36:346-351 (Pubitemid 23106020)
33. Bock G, Chittilapilly E, Basu R, et al. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis. Diabetes 2007;56:1703-1711 (Pubitemid 46842609)
34. Mevorach M, Giacca A, Aharon Y, Hawkins M, Shamoon H, Rossetti L. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest 1998;102:744-753 (Pubitemid 28399607)
35. Hawkins M, Gabriely I, Wozniak R, Reddy K, Rossetti L, Shamoon H. Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects. Diabetes 2002;51:2179-2189 (Pubitemid 34729023)
36. van Dijk TH, van der Sluijs FH, Wiegman CH, et al. Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. A pharmacological study with the chlorogenic acid derivative S4048. J Biol Chem 2001;276:25727-25735
37. Aiston S, Trinh KY, Lange AJ, Newgard CB, Agius L. Glucose-6-phosphatase overexpression lowers glucose 6-phosphate and inhibits glycogen synthesis and glycolysis in hepatocytes without affecting glucokinase translocation. Evidence against feedback inhibition of glucokinase. J Biol Chem 1999;274:24559-24566
38. Massillon D, Barzilai N, Chen W, Hu M, Rossetti L. Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats. J Biol Chem 1996;271:9871-9874 (Pubitemid 26131536)
39. Aiston S, Green A, Mukhtar M, Agius L. Glucose 6-phosphate causes translocation of phosphorylase in hepatocytes and inactivates the enzyme synergistically with glucose. Biochem J 2004;377:195-204 (Pubitemid 38114446)
40. Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J 2008;414:1-18
41. Ekberg K, Landau BR, Wajngot A, et al. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes 1999;48:292-298 (Pubitemid 29061101)
42. Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest 1998;102:619-624 (Pubitemid 28376164)
43. 2O. Magn Reson Med 2005;54:429-434
44. 13C NMR study of gluconeogenesis and TCA cycle flux in humans. Am J Physiol Endocrinol Metab 2001;281:E848-E856
45. 13C NMR isotopomer analysis of human urine. Anal Biochem 2003;312:228-234
46. 2H nuclear magnetic resonance spectroscopy. Diabetes 2003;52:2475-2482
47. Pehling G, Tessari P, Gerich JE, Haymond MW, Service FJ, Rizza RA. Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. J Clin Invest 1984;74:985-991 (Pubitemid 14031038)
48. Yki-Järvinen H, Koivisto VA. Natural course of insulin resistance in type I diabetes. N Engl J Med 1986;315:224-230 (Pubitemid 16097124)